AphriHelios Global, LLC
$25,350
amount committed
$10k - $107k
funding goal
Regulation CF
exemption used
$18,563,000
pre money valuation
$250.00
min investment
40
investors
Security Type
Discount Rate: 20%
Valuation Cap: $15M
Term: 2 years
Early Bird Bonus!
Investors who purchase the first 1,000 Units of Convertible Notes will receive an additional 15% Preferred Shares at conversion in a Qualified Equity Financing.
Volume Bonus!
Based on the size of your investment, you can also get bonus shares regardless of if you are an “early bird” investor or not! Early bird investors get both bonus percentages added together (an early bird investment of $5,000 would receive a 25% bonus, 10%+15%)
$5,000+ - 10% additional Conversion Shares
$10,000+ - 12.5% additional Conversion Shares
$20,000+ - 15% additional Conversion Shares
$50,000+ - 25% additional Conversion Shares
AphriHelios seeks to become a pan-African, vertically integrated medicinal cannabis company by leveraging Africa’s, and particularly Lesotho’s, comparative advantage as a low-cost producer. Warm climates, rich soil, and a long history and expertise in agriculture mean parts of the African continent have the potential to be pivotal markets for cultivation.
The cannabis industry is exploding and is likely to grow even faster in the US as recent political shifts will likely lead to decriminalization and legalization at the federal level. This shift will open up the US market for AphriHelios to import, at scale, African-grown, high-quality, low-production-cost cannabis.
AphriHelios will vertically integrate through a phased approach that allows the company to sustainably migrate down the value chain. The company will cement its position as a high-quality, low-cost producer while building an innovative and exciting product and brand platform that build brands and products around well-known cultural, social, sports, and entertainment influencers.
Updates

As our way of thanking our investors, we're launching Investor Perks:
Early Bird Perk
Investors who purchase the first 1,000 Units of Convertible Notes will receive an additional 15% Preferred Shares at conversion in a Qualified Equity Financing.
Volume Perks
$5,000 - $9,999 – 10% additional Preferred Shares at conversion in a Qualified Equity Financing
$10,000 - $19,999 – 12.5% additional Preferred Shares at conversion in a Qualified Equity Financing
$20,000 - $49,999 – 15% additional Preferred Shares at conversion in a Qualified Equity Financing
$50,000+ – 25% additional Preferred Shares at conversion in a Qualified Equity Financing

Q&A
Unfortunately, this securities offering is closed. For questions, please email info@fundanna.com. Thanks!


2 years ago

2 years ago
Other Disclosures
Special Note Regarding Forward-Looking Statements
Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.